NanoViricides (NNVC) Income Statement: Revenue & Earnings

NanoViricides Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

NanoViricides, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	5.55	5.44	6.39	5.78	6.11
Selling, General & Administrative	4.04	3.08	2.55	2.33	2.63
Operating Expenses	9.59	8.52	8.94	8.11	8.74
Operating Income	-9.59	-8.52	-8.94	-8.11	-8.74
Other Income/Expense
Interest Income	0.12	0.27	0.36	0.01	0.01
Interest Expense	0.00	-0.05	0.00	-0.01	-0.09
Other Income/Expense	0.12	0.00	0.00	0.00	0.00
Income
Income Before Tax	-9.47	-8.29	-8.59	-8.11	-8.82
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-9.47	-8.29	-8.59	-8.11	-8.82
Net Income - Continuous Operations	-9.47	-8.29	-8.59	-8.11	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-8.72	-7.76	-7.84	-7.39	-8.04
EBIT	-9.59	-8.52	-8.59	-8.11	-8.74
Depreciation & Amortization	0.74	0.76	0.75	0.72	0.70
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-1.00	-1.00
Diluted EPS	-1.00	-1.00	-1.00	-1.00	-1.00
Basic Shares Outstanding	15.12	11.87	11.63	11.53	10.90
Diluted Shares Outstanding	15.12	11.87	11.63	11.53	10.90